Taylor, David M <br/><br/>
Paliperidone palmitate: factors predicting continuation with treatment at 2 years.  [electronic resource] 

 -  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology  12 2016 
 - 2011-2017 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1873-7862 
<br/><br/><label>Standard No.: </label>10.1016/j.euroneuro.2016.09.638  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Ambulatory Care<br/>Antipsychotic Agents--administration & dosage<br/>Delayed-Action Preparations<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Paliperidone Palmitate--administration & dosage<br/>Psychotic Disorders--drug therapy<br/>Recurrence<br/>Risk Assessment<br/>Risperidone--therapeutic use<br/>Schizophrenia--drug therapy<br/>Socioeconomic Factors<br/>Young Adult